In this webinar, Professor Cooper will present a clinical assessment strategy in which specific anti-osteoporosis treatment (for example antiresorptive or anabolic) is targeted on the basis of fracture risk. He will review recent IOF-ESCEO guidance for the diagnosis and management of postmenopausal osteoporosis, which proposes a practical algorithm to facilitate the screening and treatment of individuals at increased risk of fracture, with choice of medication tailored to whether an individual is judged to be at low, high, or very high fracture risk. He will also explore current approaches which might inform the categorisation of high and very high fracture risk, such as FRAX probability incorporating the effect of recency and site of prior fracture. Finally, Professor Cooper will elaborate on the expected health impact of this more refined characterisation of risk on treatment strategies

KEY LEARNING OBJECTIVES OF THIS WEBINAR INCLUDE:
• To review the new IOF-ESCEO algorithm for the management of patients incorporating stratification of specific treatments based on fracture risk

• To learn the appropriate interpretation in patients' ten-year fracture probability of a major osteoporotic fracture and to follow appropriate interventions

• To recognise clinical factors that are likely to identify patients as at very high fracture risk

• To understand the place of optimised anabolic therapy in the risk stratified approach

Register